NaDeNo
Oslo, NO · 2 known investors
NaDeNo develops nanoparticle drug delivery technology that encapsulates hard-to-deliver molecules through a proprietary one-step process without chemical modification. The platform serves pharmaceutical companies and biotech partners seeking to improve formulation of poorly soluble or hydrophobic therapeutics.
Founders & leadership
AF
Annbjørg FalckCo-founder & Chief Executive Officer
YM
Yrr MørchinCo-founder & Chief Technology Officer
Investors · 2
Frequently asked questions
- What does NaDeNo do?
- NaDeNo develops nanoparticle drug delivery technology that encapsulates hard-to-deliver molecules through a proprietary one-step process without chemical modification. The platform serves pharmaceutical companies and biotech partners seeking to improve formulation of poorly soluble or hydrophobic therapeutics.
- Who founded NaDeNo?
- NaDeNo was founded by Annbjørg Falck, Yrr Mørch.
- Who are NaDeNo's investors?
- NaDeNo's investors include Farvatn Venture, Sondo Capital.
- Where is NaDeNo headquartered?
- NaDeNo is headquartered in Oslo, NO.